Latest news

• Pfizer/BioNTech file for FDA approval for COVID-19 booster jab

  Pfizer and BioNTech have filed a supplemental Biologics License Application (sBLA) with the US Food and Drug Administration (FDA) for the approval of a third dose of their Cominarty COVID-19 ... Levels of neutralising titers present after the third dose

• Protection against COVID-19 reduces over time in fully vaccinated, according to new real-world study

  out of a third jab – initially expected to start in September. ... Speaking about the need for a booster jab, Spector said: "Many people may not need them.

• FDA opens door to COVID-19 booster jabs

  The FDA has amended its emergency use authorisations for both approved mRNA vaccines – Pfizer/BioNTech’s Comirnaty and Moderna’s Spikevax – for use as a booster/third jab for “certain immunocompromised ... third jab and several countries,

• Pfizer, BioNTech eye US approval for COVID-19 booster dose

  a third dose of its BioNTech-partnered jab, compared to after a second dose. ... However, even if the booster dose is approved, it may not immediately mean that individuals will be offered a third jab.

• Moderna COVID-19 vaccine shortfall could affect UK supply

  The Moderna vaccine is the third jab to be rolled out in the UK.